Clasificar por
Medicine and Dentistry
Serotype
100%
Pneumococcus Vaccine
71%
Infection
69%
Meningococcal Disease
64%
Diseases
63%
Public Health
40%
COVID-19
31%
Pneumococcal Infection
29%
Neisseria meningitidis
26%
Cohort Effect
20%
Pediatrics
19%
Cost-Effectiveness Analysis
19%
Observational Study
18%
Pneumococcus
17%
Health Care Cost
16%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Conjugate Vaccine
16%
Wart Virus Vaccine
15%
Mycobacterium Bovis BCG
15%
Breast Cancer
15%
Pneumococcal Meningitis
15%
Surveillance System
15%
Prevalence
12%
Cervical Cancer
12%
Primary Health Care
11%
Penicillin Derivative
11%
Community-Acquired Pneumonia
11%
Adolescence
11%
Mass Immunization
11%
COVID-19 Vaccine
10%
Disability Adjusted Life Years
10%
Meningitis
10%
Immunogenicity
9%
Case Fatality Rate
9%
Health Care
9%
Polysaccharide Vaccine
9%
Rotavirus Vaccine
9%
Intussusception
9%
Streptococcus Pneumonia
9%
Adverse Event
8%
Cohort Analysis
8%
Case Definition
8%
Non-Pharmaceutical Intervention
8%
Mortality Rate
8%
Malignant Neoplasm
7%
Household
7%
Serotype
7%
Pneumococcus Polysaccharide
7%
Pneumococcal Pneumonia
7%
Case-Control Study
7%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
95%
Pneumococcus Vaccine
85%
Pneumococcal Infection
52%
Infection
50%
Immunogenicity
34%
Streptococcus
24%
Community Acquired Pneumonia
20%
Vaccination
17%
SARS Coronavirus
17%
Pneumococcal Meningitis
16%
Wart Virus Vaccine
15%
Hepatitis A
15%
Hepatitis B
15%
Drug Resistance
15%
Breast Cancer
15%
Observational Study
15%
Meningococcosis
15%
Diseases
15%
Bloodstream Infection
13%
Prevalence
13%
Meningitis
13%
Penicillin Derivative
12%
Measles
11%
Malignant Neoplasm
10%
Neutralizing Antibody
10%
Neisseria meningitidis
9%
Case-Control Study
8%
Elimination
8%
Tetanus
7%
Coronavirinae
7%
Enkephalin
7%
Aminopeptidase
7%
BCG Vaccine
7%
Maternal Mortality
7%
Intestinal Intussusception
7%
Intussusception
7%
Disease Surveillance
7%
Haemophilus Influenzae Type B
7%
Placebo-Controlled Study
7%
Epstein-Barr Virus
7%
Pneumococcus Polysaccharide
7%
Polysaccharide Vaccine
7%
Papillomaviridae
7%
Mycobacterium Bovis BCG
7%
Negative Syndrome
7%
Epidemic Meningitis
7%
N-Nitroso-N-Methylurea
7%
Thiomersal
7%
Tolerability
7%
Antibiotic Resistance
7%
Immunology and Microbiology
Serotype
80%
Neisseria meningitidis
28%
Immunogenicity
26%
Immunology
25%
Pneumococcal Vaccine
23%
Adolescence
23%
Severe Acute Respiratory Syndrome Coronavirus 2
23%
Neutralizing Antibody
16%
Infectious Disease
15%
Pneumococcus
14%
Prevalence
13%
COVID-19
8%
Neutralization
8%
Meningitis
8%
Drug Dose Regimen
8%
Titer
8%
Radioresistance
7%
Rubella
7%
Measles
7%
Pneumococcal Polysaccharide Vaccine
7%
Omicron Coronavirus Variant
7%
Humoral Immunity
7%
Serotype
7%
Neisseria meningitidis
7%
DNA Damage
7%
Haemophilus Influenzae Type B
7%
Antibody Response
7%
Plasmodium
7%
Drug Resistance
7%
Real Time Polymerase Chain Reaction
7%
Hepatitis B
7%
Mycobacterium Bovis BCG
7%
Immunodeficiency
7%
Immunity
7%
Disability-Adjusted Life Year
7%
Immune Response
6%
Lymphocyte
5%
Conjugate Vaccine
5%
DPT Vaccine
5%
Multilocus Sequence Typing
5%
